WeightWatchers CEO suddenly quits after push to embrace weight-loss drugs like Ozempic, Wegovy
Sima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.
WeightWatchers to offer compounded GLP-1 weight-loss drugs
WeightWatchers said it will sell compounded versions of semaglutide — the key ingredient in Novo Nordisk's Ozempic and Wegovy.
WeightWatchers CEO who oversaw move into weight loss drugs abruptly leaves role
WW International announced Friday that CEO Sima Sistani would leave her role effective immediately. Tara Comonte, a WeightWatchers board member and former Shake Shack executive, was made interim chief executive.
WeightWatchers is getting in on the off-brand weight loss drug game — and selling them cheap
WeightWatchers (WW) announced Tuesday that it is now offering off-brand weight loss drugs for one of the cheapest prices in the industry.
WeightWatchers cashes in on popularity of weight loss drugs with compounded semaglutide
WW International (NASDAQ:WW), more commonly known as WeightWatchers, will now offer compounded semaglutide to its WeightWatchers Clinic members, expanding the accessibility of popular weight loss medications to its members at a more affordable price.
WeightWatchers Adds Compounded GLP-1, Expanding Accessibility and Affordability of Weight Loss Medications
WeightWatchers (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) announced today the addition of compounded semaglutide into its offering, broadening eligible members’ access to clinical weight management interventions that are underpinned by the comprehensive,
WeightWatchers adds compounded version of Novo’s obesity drug to weight-loss program
WeightWatchers said on Tuesday it would offer compounded form of Novo Nordisk's popular obesity drug Wegovy as part of its weight-management programs, sending its shares up 13% in early trading. Soaring demand for weight-loss drugs such as
WeightWatchers Stock Soars on Copycat Weight-Loss Drug Offering
Shares of WW International, better known as WeightWatchers, soared Tuesday after it said it is offering copycat weight-loss drugs to its members.
WeightWatchers stock price skyrockets on news that it will offer a compounded GLP-1 weight-loss drug like Wegovy
The embattled diet brand said it is adding a compounded weight-loss drug in accordance with FDA rules and manufacturing standards. WeightWatchers announced on Tuesday that it will offer a compounded version of Novo Nordisk‘s popular weight-loss drug Wegovy as part of its weight-management programs,
4029tv2h
The end of a shortage of popular weight-loss drugs may mean many people lose access to them
CARRY RISK. WEIGHT WATCHERS SAYS IT WILL NOW OFFER ELIGIBLE MEMBERS COMPOUNDED SEMAGLUTIDE AS PART OF ITS HOLISTIC ...
The Holy Mess on MSN9d
New Updates! Weight Watchers Changes for 2024
What’s going on with Weight Watchers? With the CEO stepping down, a new body-positive approach, continual app changes, ...
Hosted on MSN2d
WeightWatchers (NASDAQ:WW) Stock Jumps 40% on Plan to Sell Obesity Medications
Shares of WeightWatchers parent company WW International ($WW) have rocketed 40% higher on news that the company plans to ...
Weight Watchers Stock Rises 38% On Plan To Sell Obesity Drugs
Shares of Weight Watchers parent company WW International (WW) rose nearly 40% after the company announced plans to begin ...
Cook Eat Go on MSN2d
3 Ingredient Strawberry Weight Watcher Muffins!
Weight Watchers Strawberry Muffins are the perfect light treat to make at home! I am a huge fan of baking, and the easie ...